Which patients with diabetes should undergo ambulatory blood pressure monitoring?

Journal of Hypertension

Volumn 29, Issue 2, 2011, Pages 236-241

  Leitão, Cristiane B ^a   Rodrigues, Ticiana C ^a   Kramer, Caroline K ^a   Schreiner, Luciana R ^a   Pinto, Lana C ^a   Ricardo, Eliza D ^a   Biavatti, Karina ^a   Canani, Luís H ^a   Gross, Jorge L ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

ambulatory blood pressure monitoring; blood pressure; diabetes; reference levels

Indexed keywords

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CROSS-SECTIONAL STUDY; DEVICE; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSCILLOMETRY; PRIORITY JOURNAL; REFERENCE VALUE; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

EID: 78651273888     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834068c3     Document Type: Article

References (32)

1. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317:703-713.
2. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321:412-419.
3. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104:1385-1392.
4. Rodrigues TC, Canani LH, Viatroski RS, Hoffmann LH, Esteves JF, Gross JL. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract 2010; 87:240-245.
5. Leitao CB, Canani LH, Polson PB, Molon MP, Pinotti AF, Gross JL. Urinary albumin excretion rate is associated with increased ambulatory blood pressure in normoalbuminuric type 2 diabetic patients. Diabetes Care 2005; 28:1724-1729.
6. Leitao CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Gross JL. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care 2007; 30:1255-1260.
7. Kramer CK, Leitao CB, Canani LH, Gross JL. Impact of white-coat hypertension on microvascular complications in type 2 diabetes. Diabetes Care 2008; 31:2233-2237.
8. Knudsen ST, Poulsen PL, Hansen KW, Ebbehoj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens 2002; 15:244-250.
9. Knudsen ST, Laugesen E, Hansen KW, Bek T, Mogensen CE, Poulsen PL. Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients. Diabetologia 2009; 52:698-704.
10. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz JE, et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens 2008; 21:443-450.
11. Da Costa Rodrigues T, Pecis M, Azevedo MJ, Esteves JF, Gross JL. Ambulatory blood pressure monitoring and progression of retinopathy in normotensive, normoalbuminuric type 1 diabetic patients: a 6-year followup study. Diabetes Res Clin Pract 2006; 74:135-140.
12. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415.
13. Ben-Dov IZ, Kark JD, Mekler J, Shaked E, Bursztyn M. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. J Hypertens 2008; 26:699-705.
14. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 2007; 49:1235-1241.
15. Mancia G, Giannattasio C, Turrini D, Grassi G, Omboni S. Structural cardiovascular alterations and blood pressure variability in human hypertension. J Hypertens Suppl 1995; 13:S7-14.
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
17. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. Normal ambulatory blood pressure: a clinical practice-based comparison of two recently published definitions. J Hum Hypertens 2005; 19:565-567.
18. Standards of Medical Care in Diabetes-2010. Diabetes Care 2010; 33 (Suppl 1):S11-S61.
19. Hypertension in people with type 2 diabetes: knowledge-based diabetesspecific guidelines. Diabet Med 2003; 20:972-987.
20. Bakris GL, Ritz E. The message for World Kidney Day 2009: hypertension and kidney disease - a marriage that should be prevented. J Hypertens 2009; 27:666-669.
21. Parati G, Bilo G. Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care 2009; 32 (Suppl 2): S298-S304.
22. Mancia G, Sega R, Bombelli M, Quarti-Trevano F, Facchetti R, Grassi G. Should white-coat hypertension in diabetes be treated? Pro Diabetes Care 2009; 32 (Suppl 2):S305-S309.
23. Bursztyn M, Ben-Dov IZ. White-coat hypertension should not be treated in subjects with diabetes. Diabetes Care 2009; 32 (Suppl 2):S310-S313.
24. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207, Novacor DIASYS 200, Del Mar Avionics Pressurometer IV and Takeda TM-2420 ambulatory systems according to British and American criteria. J Hypertens 1991; 9 (Suppl):S332-S333.
25. Leitao CB, Canani LH, Kramer CK, Moehlecke M, Pinto LC, Ricardo ED, et al. Blood pressure means rather than nocturnal dipping pattern are related to complications in type 2 diabetic patients. Diabet Med 2008; 25:308-313.
26. Hansen KW, Poulsen PL, Ebbehoj E, Mogensen CE. What is hypertension in diabetes? Ambulatory blood pressure in 137 normotensive and normoalbuminuric type 1 diabetic patients. Diabet Med 2001; 18:370-373.
27. Rodrigues TC, Leitão CB, Kramer CK, Schreiner LR, Pinto LC, Ricardo ED, et al. The 'white-coat effect' is more relevant at higher office blood pressure levels. Diabetes 2009; 58 (Suppl 1):827; (abstract).
28. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351:1755-1762. (Pubitemid 28269185)
29. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
30. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-1585.
31. Gomes MA, Pierin AM, Mion D Jr. The effect of siesta in parameters of cardiac structure and in interpretation of ambulatory arterial blood pressure monitoring. Arq Bras Cardiol 2000; 74:314-318.
32. Kikuya M, Hansen TW, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Blood Press Monit 2007; 12:393-395.